InvestorsHub Logo
Followers 3
Posts 191
Boards Moderated 0
Alias Born 04/19/2006

Re: None

Monday, 03/07/2016 10:45:29 AM

Monday, March 07, 2016 10:45:29 AM

Post# of 345969
another control arm outperforms

In the ACT IV study, RINTEGA has performed consistently with prior Phase 2 studies but the control arm has significantly outperformed expectations...

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News